I am listening again , Dr Patterson said September 12 , that we could stop developing of resistance to checkpoint inhibitors , here he said we can be complementary to CAR-T treatment

We know it is very positive with chemotherapy , so its look that it will be beneficial for patients with any other cancer treatment to be also on Leronlimab ..

This is really exciting for patients and us all. !!!!!

IMO of course.